Cargando…
Molecular Subgroup Is the Strongest Predictor of Medulloblastoma Outcome in a Resource-Limited Country
Medulloblastoma is composed of four clinically and prognostically distinct molecular subgroups (WNT, SHH, group 3, and group 4). However, the clinical implications of these subgroups in the context of the unique challenges of low- to middle-income countries are rarely reported. METHODS: We assembled...
Autores principales: | Amayiri, Nisreen, Swaidan, Maisa, Ibrahimi, Ahmed, Hirmas, Nader, Musharbash, Awni, Bouffet, Eric, Al-Hussaini, Maysa, Ramaswamy, Vijay |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8492378/ https://www.ncbi.nlm.nih.gov/pubmed/34609903 http://dx.doi.org/10.1200/GO.21.00127 |
Ejemplares similares
-
Video-Teleconferencing in Pediatric Neuro-Oncology: Ten Years of
Experience
por: Amayiri, Nisreen, et al.
Publicado: (2017) -
Advances in managing medulloblastoma and intracranial primitive neuro-ectodermal tumors
por: Adamski, Jenny, et al.
Publicado: (2014) -
Subgroup-specific prognostic signaling and metabolic pathways in pediatric medulloblastoma
por: Park, Ae Kyung, et al.
Publicado: (2019) -
Novel mutations target distinct subgroups of medulloblastoma
por: Robinson, Giles, et al.
Publicado: (2012) -
The strongest force
por: Ne'eman, Yuval
Publicado: (1969)